The treatment of endometrial hyperplasia depends on histologic type, patients' age and whether the hyperplasia is a result of endogenous or exogenous oestrogen overexpression. The risk for progression to invasive cancer is minimal in oestrogen treated patients with simple or complex hyperplasia without atypia.

Estimate age-specific incidence of endometrial hyperplasia: simple, complex, and atypical, in order of increasing likelihood of progression to carcinoma. patients and the health care system bear the cost and burden of diagnostic evaluations and surgical and medical treatment (including Endometrial Cancer: ESMO Clinical Practice Guidelines. MASCC and ESMO consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting • Treatment of dyspnoea in advanced cancer patients • Central venous access in oncology • Management of oral and Endometrial hyperplasia, a thickening of the lining of the uterus, is not cancer although in some cases can lead to cancer, explains this ACOG patient FAQ. How much and how long you take it depends on your age and the type of hyperplasia. Treatment with progestin may cause vaginal bleeding Endometrial Hyperplasia Information Including Symptoms, Diagnosis, Treatment, Causes, Videos, Forums, and local community support. Find answers to health issues you can trust from Healthgrades.com AAGL Practice Report: Practice Guidelines for the Diagnosis and a treatment for endometrial polyps or to prevent their devel- appears to increase the risk of atypical hyperplasia and malignancy in endometrial polyps [3,45,46]. Endometrial hyperplasia frequently results from chronic estrogen stimulation unopposed by the counterbalancing effects of progesterone . The classification, epidemiology, risk factors, diagnosis, and evaluation of endometrial hyperplasia are reviewed here. Related topics can be found separately: Most guidelines recommend either The mainstay of treatment for endometrial cancer is t